David E. I. Pyott, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 3,830 shares at $297.71 ($1.1M) on 2026-06-01, disclosed to the SEC on 2026-06-03.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $297.71 | 921 | $274K | 23.9% |
| 2 | $298.91 | 1,175 | $351K | 30.7% |
| 3 | $299.87 | 1,222 | $366K | 32.0% |
| 4 | $300.72 | 495 | $149K | 13.0% |
| 5 | $302.65 | 17 | $5K | 0.4% |
| Total | $299.18 avg | 3,830 |
| $1.1M |
| 100% |
| Filing → |
| BMRN | BUY | 2020-09-01 | $1.0M | — | Filing → |
| AVY | SELL | 2020-02-05 | $1.3M | — | Filing → |
| AVY | SELL | 2018-11-28 | $186K | — | Filing → |